Andrew Rubinstein

Mr. Rubinstein is a Managing Partner at Oberland Capital. Previously, he was a Partner at Paul Capital, where he co-managed the firm's healthcare royalty platform. Prior to joining Paul Capital, he was CEO of Microban International, Ltd. a global licensing business focused on antimicrobial technologies. Mr. Rubinstein had previously worked as an investment banker in the Financial Sponsors Group at Merrill Lynch & Co. He earned a B.A. from the University of Pennsylvania, a J.D. from New York University School of Law, and an M.B.A. from New York University Stern School of Business.